Hendley & Co
AZN icon

Hendley & Co’s AstraZeneca AZN Stock Holding History

Hendley & Co’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.39M Buy
33,378
+973
+3% +$162K 1.88% 21
2026
Q2 		$6.14M Buy
32,405
+28
+0.1% +$5.27K 2.17% 18
2026
Q1 		$6.38M Sell
32,377
-26
-0.1% -$5.01K 2.36% 19
2025
Q4 		$5.96M Sell
32,403
-4,207
-11% -$738K 2.13% 17
2025
Q3 		$5.62M Sell
36,610
-235
-0.6% -$35.6K 1.86% 19
2025
Q2 		$5.15M Buy
36,845
+325
+0.9% +$45.5K 1.8% 19
2025
Q1 		$5.37M Buy
36,520
+13,130
+56% +$1.9M 1.88% 17
2024
Q4 		$3.06M Buy
23,390
+360
+2% +$50.4K 1.08% 33
2024
Q3 		$3.59M Sell
23,030
-75
-0.3% -$12.1K 1.25% 31
2024
Q2 		$3.6M Sell
23,105
-200
-0.9% -$30.1K 1.29% 29
2024
Q1 		$3.16M Hold
23,305
– – 1.13% 30
2023
Q4 		$3.14M Sell
23,305
-25
-0.1% -$3.25K 1.22% 30
2023
Q3 		$3.16M Buy
23,330
+20,830
+833% +$2.84M 1.27% 29
2023
Q2 		$358K Hold
2,500
– – 0.15% 44
2023
Q1 		$347K Hold
2,500
– – 0.16% 45
2022
Q4 		$339K Hold
2,500
– – 0.15% 48
2022
Q3 		$274K Hold
2,500
– – 0.13% 52
2022
Q2 		$330K Hold
2,500
– – 0.14% 53
2022
Q1 		$332K Hold
2,500
– – 0.11% 64
2021
Q4 		$291K Hold
2,500
– – 0.1% 66
2021
Q3 		$300K Hold
2,500
– – 0.1% 67
2021
Q2 		$300K Hold
2,500
– – 0.1% 66
2021
Q1 		$249K Sell
2,500
-2,000
-44% -$201K 0.09% 68
2020
Q4 		$450K Hold
4,500
– – 0.17% 53
2020
Q3 		$493K Buy
+4,500
New +$501K 0.21% 55

Other funds holding AZN

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
ASR Vermogensbeheer
ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return
Generali Asset Management
Generali Asset Management Trieste, Italy $5.73B AUM 29.6% 1-Year Est. Return

Hendley & Co's AZN Position: Q3 2026 in Review

Hendley & Co increased its AstraZeneca (AZN) stake by 3% in Q3 2026, buying an estimated $162K and bringing the position to 33,378 shares worth $5.39M. The position accounts for 1.88% of the portfolio, ranked #21.

Hendley & Co first reported a position in AZN in Q3 2020 and has held it in 25 quarters since. The position peaked at $6.38M in Q1 2026. 581 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Hendley & Co held 33,378 shares of AstraZeneca worth $5.39M as of Q3 2026.
  • Hendley & Co bought 973 AstraZeneca shares in Q3 2026, an estimated $162K.
  • AstraZeneca made up 1.88% of Hendley & Co's portfolio in Q3 2026, its #21 holding.
  • Hendley & Co first reported a position in AstraZeneca in Q3 2020 and has held it in 25 quarters since.
  • Hendley & Co's AstraZeneca position peaked at $6.38M in Q1 2026.
  • 581 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Hendley & Co's 13F filing for Q3 2026, filed 29 Oct 2026.